#United States #New York #Levi & Korsinsky #PepGen Inc. #PEPG

Investors Alert: PepGen Inc. Lawsuit and Key Deadlines

Levi & Korsinsky, LLP has issued an important notification for investors involved with PepGen Inc. (NASDAQ: PEPG). The law firm is currently managing a class action securities lawsuit against the company, centered on allegations of securities fraud. This lawsuit could have considerable implications for affected investors, as it seeks to recover losses incurred due to misleading statements made by company executives regarding product efficacy and safety.

What You Need to Know

Lawsuit Timeline

The lawsuit encompasses a specific time frame from March 7, 2024, to March 3, 2025, during which the alleged fraud occurred. Investors who have suffered financial losses due to this fraud can take action by submitting a request to be appointed as a lead plaintiff. Importantly, the deadline for this action is August 8, 2025.

Allegations Against PepGen Inc.

The complaint filed in court outlines several serious allegations against PepGen's management regarding their lead product candidate, PGN-EDO51. Key claims include:

• - Efficacy Misrepresentation: The lawsuit alleges that PepGen’s executives misrepresented the effectiveness and safety of PGN-EDO51, creating false expectations among investors.
• - Issues with Phase Two Study: The second phase of the CONNECT2 study—critical for U.S. Food and Drug Administration (FDA) approval—has been described as potentially dangerous and unsuitable. Investors and analysts are concerned about the implications of this study's shortcomings on the company's future and its products’ market readiness.
• - Halting of CONNECT2 Study: The allegations further suggest that due to these deficiencies, PepGen may be compelled to halt the CONNECT2 study, casting doubt on the commercial viability of PGN-EDO51 and its development trajectory.
• - Inaccurate Public Statements: Because of these issues, management’s public communications were reportedly misleading, which adversely affected investor decisions and company stock values.

Steps for Investors

If you believe you have been significantly impacted by the circumstances surrounding PepGen Inc., you should consider filing a claim. Engaging with the legal team at Levi & Korsinsky could provide a pathway for you to potentially reclaim some of your financial losses without any out-of-pocket costs. They emphasize that participation in the lawsuit entails no financial obligation at the outset.

About Levi & Korsinsky, LLP

With over two decades of experience, Levi & Korsinsky has successfully represented shareholders in securities litigation across a multitude of high-stakes cases, securing hundreds of millions in damages. The firm’s impressive record is underscored by a consistent ranking amongst the top securities litigation firms in the United States. Their expertise in handling complex cases makes them a trusted partner for investors seeking redress for corporate malfeasance.

Feel free to reach out to the firm directly:

• - Contact: Joseph E. Levi, Esq.
• - Phone: (212) 363-7500
• - Email: [email protected]

For detailed information and to view the full legal notice, visit the firm's official site here.

Conclusion

The PepGen Inc. lawsuit highlights the critical importance of transparency and accountability in corporate practices. Investors are encouraged to act swiftly, as the deadline for lead plaintiff requests is fast approaching. Staying informed and taking necessary legal actions could prove essential for those affected by the company’s alleged misrepresentations.